11/15
05:59 am
adil
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Low
Report
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
11/14
08:42 am
adil
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder [Yahoo! Finance]
Low
Report
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder [Yahoo! Finance]
11/14
08:30 am
adil
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Medium
Report
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
11/14
07:35 am
adil
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
High
Report
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
11/13
08:30 am
adil
Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
08:30 am
adil
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
Low
Report
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
10/23
09:00 am
adil
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
Medium
Report
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
10/17
09:00 am
adil
Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
High
Report
Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
10/17
08:51 am
adil
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate [Yahoo! Finance]
Medium
Report
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate [Yahoo! Finance]
10/15
09:00 am
adil
Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery
Medium
Report
Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery
9/19
08:30 am
adil
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Medium
Report
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
9/4
09:00 am
adil
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference